首页> 外文期刊>Gene Therapy and Molecular Biology >Human cytomegalovirus (HCMV) nuclease:implications for new strategies in gene therapy
【24h】

Human cytomegalovirus (HCMV) nuclease:implications for new strategies in gene therapy

机译:人类巨细胞病毒(HCMV)核酸酶:对基因治疗新策略的启示

获取原文
           

摘要

Human cytomegalovirus (HCMV), one of eight human herpesviruses, can cause serious illness in neonates as well as in immunocompromised adults (Alford and Britt, 1993). Transplant and AIDS patients, e.g. may develop life- threatening diseases as a consequence of primary infection or reactivation of latent infection. Additionally, HCMV infections are also associated with congenital neurological complications in approximately 7,500 newborns annually (Alford and Britt, 1993). The current drugs are toxic and cause additional complications including drug resistance. Since present therapeutical approaches are limited new strategies are needed that may result from a better understanding of viral molecular biology.
机译:人类巨细胞病毒(HCMV)是八种人类疱疹病毒之一,可在新生儿以及免疫功能低下的成年人中引起严重疾病(Alford and Britt,1993)。移植和艾滋病患者,例如初次感染或潜伏感染的重新激活可能导致威胁生命的疾病。此外,每年大约有7,500名新生儿中,HCMV感染还与先天性神经系统并发症相关(Alford和Britt,1993)。当前的药物是有毒的,并引起包括耐药性在内的其他并发症。由于目前的治疗方法是有限的,需要新的策略,这可能是由于对病毒分子生物学的更好理解而产生的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号